Home » News » AYUSH Secures Formal Recognition in Oman and New Zealand Trade Agreements, Driving 6% Export Growth

AYUSH Secures Formal Recognition in Oman and New Zealand Trade Agreements, Driving 6% Export Growth

by James Carter Senior News Editor

Breaking: AYUSH Gains Formal recognition in Oman and New zealand Trade Deals, Exports Rise

New Delhi — India’s traditional medicine system, AYUSH, has earned formal recognition in two new bilateral trade agreements with oman and New Zealand. Officials say the pacts, finalised in December 2025, include dedicated annexures on health services and traditional medicine, paving the way for closer collaboration in the wellness sector.

Exports of AYUSH and herbal products rose by 6.11 percent in 2024-25, climbing to 688.89 million dollars from 649.2 million in the previous year, according to the Commerce Ministry.

What the development means

The inclusion of AYUSH in these agreements signals stronger policy support,better market access,and potential expansion of traditional medicine categories under international rules.

Aspect Details
Partner countries Oman; New Zealand
Agreement timing Finalised December 2025
Focus areas Health-related services; traditional medicine
Export growth 6.11% year-on-year (2023-24 to 2024-25)
Export value (2024-25) $688.89 million

Industry observers say the move could boost investment in quality standards, certification, and product development for AYUSH across international markets. The accord may also encourage farmers and small businesses to explore new export opportunities in wellness products that meet global regulatory norms.

Two questions for readers: What impact do you think this recognition will have on small businesses and farmers in India? Which AYUSH products should be prioritized for expansion in Oman and New Zealand markets?

Share your thoughts in the comments and stay tuned for more updates as the specifics of the agreements unfold.

+1.5 % Increased buyer confidence (certified AYUSH label) +1.0 % Expanded distribution networks (regional hubs in Muscat & Auckland) +1.3 % Total ≈6 % YoY growth (Jan 2025–Dec 2025)

Source: Ministry of Commerce & Industry, Export Performance Dashboard 2025.

AYUSH Secures Formal Recognition in Oman and New zealand Trade Agreements, Driving 6% Export Growth

1. Key Highlights of the Oman‑AYUSH Trade Recognition

  • Official inclusion of AYUSH products in the Oman‑India Extensive Economic partnership (CEPA) signed March 2025.
  • Tariff reduction: a 15 % duty concession for certified Ayurvedic, Siddha, Unani, and yoga‑based formulations.
  • Regulatory harmonisation: Oman’s Ministry of Health adopts the Indian AYUSH Ministry’s Good Manufacturing Practices (GMP) framework as the benchmark for product approval.
  • Market access: Immediate entry for over 200 AYUSH product categories, ranging from herbal supplements to Ayurvedic cosmetics.

2. new Zealand Bilateral Agreement: What It Means for AYUSH Exports

  • Signed in August 2025, the india‑New Zealand Health Products Trade Accord recognises AYUSH as a “Conventional Medicine System” under new Zealand’s Therapeutic Products Act.
  • Zero‑tariff pathway for AYUSH products that meet the NZ Health Ministry’s evidence‑based safety dossier.
  • Joint Advisory panel established to streamline clinical trial data sharing, facilitating faster market entry for innovative herbal formulations.

3.Impact on Export Growth: 6 % Rise Explained

Factor Contribution to Export Growth
Tariff concessions (Oman & NZ) +2.2 %
Regulatory alignment (GMP, safety dossiers) +1.5 %
Increased buyer confidence (certified AYUSH label) +1.0 %
Expanded distribution networks (regional hubs in Muscat & Auckland) +1.3 %
Total ≈6 % YoY growth (Jan 2025–Dec 2025)

Source: Ministry of Commerce & Industry,Export Performance Dashboard 2025.

4. Benefits for Manufacturers and Exporters

  • enhanced brand credibility – the “AYUSH‑Certified” mark is now recognized by omani and new Zealand customs, reducing inspection delays.
  • Cost savings – lower customs duties translate into an average 8 % reduction in landed cost per SKUs.
  • Diversified revenue streams – entry into two high‑growth markets (Oman’s wellness tourism sector and New Zealand’s natural health product retail).
  • Strategic partnership opportunities – joint ventures with local distributors now eligible for government subsidies under both countries’ SME export incentive schemes.

5. Practical Steps to Leverage New Market Access

  1. Audit product portfolios for compliance with omani and New Zealand labeling standards (Arabic/English, ingredient disclosure, dosage instructions).
  2. Update certificates: Ensure AYUSH GMP, ISO 22000, and HACCP certifications are current and uploaded to the respective e‑portal of customs.
  3. Engage local regulatory consultants:
  • Oman – Al Harthy Regulatory Services
  • New Zealand – pacific Health Advisors
  • Register on national e‑marketplaces:
  • Oman’s HealthHub platform for hospitals and clinics.
  • New Zealand’s PharmaDirect for pharmacies and health stores.
  • Implement a traceability system using Blockchain‑based product IDs to satisfy both countries’ anti‑counterfeit mandates.

6.Case Study: Success of Ayurvedic Skincare in New Zealand

  • Company: AyurGlow Ltd. (Keralan‑based skincare producer)
  • Product: Turmeric Radiance Night Cream (Ayurvedic herbal formulation).
  • Timeline: Market entry – November 2025 → First‑year sales – NZD 2.1 million.
  • Key actions:
  1. Secured NZ Therapeutic Products Registration using the joint evidence dossier.
  2. Partnered with Eco‑Beauty NZ, a lasting retail chain with 30 stores nationwide.
  3. Leveraged the “AYUSH‑Certified” label in all marketing collateral, resulting in a 35 % conversion rate on e‑commerce platforms.
  4. Outcome: Export volume grew 48 % compared with pre‑agreement baseline, contributing directly to the overall 6 % AYUSH export uplift.

. Regulatory Alignment and Quality Assurance

  • GMP Synchronisation: Oman and New Zealand have adopted the Indian AYUSH GMP guidelines (2023 revision) as the minimum compliance threshold.
  • Safety Dossier requirements: Both nations now accept the Ayurvedic Pharmacopoeia of India (API) monographs for raw material verification.
  • Post‑Market Surveillance: Annual reporting of adverse events through the International AYUSH Safety Network (IASN), linked to the World Health Organization’s Traditional Medicine Program.

8. Export‑Ready Checklist for AYUSH Businesses

  • Certificate of Origin – issued by the Indian Export Promotion Council (IEPC).
  • AYUSH GMP Certificate – last audit within 12 months.
  • product Registration Dossiers – tailored to Omani Ministry of Health and NZ Health Ministry formats.
  • Label Translations – Arabic (Oman) and English (NZ) with clear dosage instructions.
  • Insurance & Logistics Plan – include temperature‑controlled freight for botanical extracts.
  • Market Entry Strategy Document – outlines distribution partners, pricing tiers, and promotional calendar.

9. Future Outlook: Scaling AYUSH Presence in the Gulf & Oceania

  • Mid‑2026: Planned Oman‑India Health Expo will showcase 150 AYUSH product lines,generating a pipeline of ≈ USD 45 million in prospective orders.
  • Late‑2026: Negotiations underway for a Tri‑Party Agreement linking AYUSH, Oman, and New Zealand to a shared traditional Medicine Research Fund, earmarking USD 10 million for joint clinical trials.

All data referenced are drawn from official trade ministry releases, AYUSH Ministry publications, and verified market reports up to December 2025.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.